Exterior of the University of Hannover, Germany

Magnachip Semiconductor Corp (NYSE:MX)’s share price soared 7% or 0.85 to reach at $13 during previous trading session. A total of 900241 shares exchanged hands, whereas the company’s average trading volume stands at 394.16 Million shares. Magnachip Semiconductor Corp (NYSE:MX) has a market capitalization of $442 Million and most recently 34 Million outstanding shares have been calculated.

According to sentiments of 3 analysts the mean estimates of short term price target for the company’s stock is marked at $13.67. The most optimistic analyst sees the stock reaching $15 while the most conventional predicts the target price at $11.

In terms of Buy/Sell recommendations, 3 analysts have a consensus rating of 2 on the shares of Magnachip Semiconductor Corp (NYSE:MX). Out of rating recommendations 0 have given the stock a Buy while 2 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Magnachip Semiconductor Corp (NYSE:MX)’s distance from 20 day simple moving average is 0.2045 along with distance from 50 day simple moving average of 11.01 whereas its distance from 200 day simple moving average is 10.39. Magnachip Semiconductor Corp (NYSE:MX)’s price distance from 52-week high is 1.96 and from 52-week low is 147.62. The stock hit its 52-week high price on 11/13/17, and 52-week low price on 11/15/16. The stock’s 52-week price fluctuated within the range of $12.75 – $5.25.

Magnachip Semiconductor Corp (NYSE:MX)’s shares climbed 17.12% in the past week and soared 18.18% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 41.3% while its year to date performance is at 109.68%.

While taking a glance at financials, we can look at a number of key indicators. Magnachip Semiconductor Corp (NYSE:MX) has a Return on Assets (ROA) of -1.7. The company currently has a Return on Equity (ROE) of 12.4 and a Return on Investment (ROI) of -0.7. Average true range (ATR-14) of the company sets at 0.53, along with its weekly and monthly volatility of 5.47% and 4.41% respectively. Relative strength index (RSI-14) for Magnachip Semiconductor Corp (NYSE:MX) is at 73.86. Beta value of the stock stands at -0.43.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 2 along with current ratio for most recent quarter of 2.4. Total debt to equity ratio of Magnachip Semiconductor Corp (NYSE:MX) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of Zynerba Pharma CS (NASDAQ:ZYNE) plunged -2.65% or -0.33 to reach at $12.11 during previous trading session. Zynerba Pharma CS (NASDAQ:ZYNE) has a market capitalization of $149.68 Million and most recently 12.36 Million outstanding shares have been calculated. A total of 892183 shares exchanged hands, whereas the company’s average trading volume stands at 832.89 Million shares.

According to 7 analysts Zynerba Pharma CS (NASDAQ:ZYNE)’s price will reach at $12.14 during 52 weeks. Stock’s minimum price target estimates has been figured out at $7 while the maximum price target forecast is established at $17.

According to the recommendations from 7 analysts stock has mean rating of 1.86 on the shares of Zynerba Pharma CS (NASDAQ:ZYNE). Out of rating recommendations 1 have given the stock a Buy while 3 recommend the stock as Outperform. 3 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Zynerba Pharma CS (NASDAQ:ZYNE) climbed 8.22% in the past week and soared 26.15% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -37.8% while its year to date performance is at -22.32%.

Zynerba Pharma CS (NASDAQ:ZYNE)’s 52-week price fluctuated within the range of $25.95 – $5.42. Its price distance from 52-week high is -53.33 and from 52-week low is 123.43. The stock hit its 52-week high price on 04/13/17, and 52-week low price on 08/14/17. Zynerba Pharma CS (NASDAQ:ZYNE)’s distance from 20 day simple moving average is0.1919 along with distance from 50 day simple moving average of 9.62 whereas its distance from 200 day simple moving average is 13.17.

Total debt to equity ratio of Zynerba Pharma CS (NASDAQ:ZYNE) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0. The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 9.7 along with current ratio for most recent quarter of 9.7.

Average true range (ATR-14) of the company sets at 0.83, along with its weekly and monthly volatility of 11.07% and 7.04% respectively. Relative strength index (RSI-14) for Zynerba Pharma CS (NASDAQ:ZYNE) is at 71.82. Beta value of the stock stands at 0. Zynerba Pharma CS (NASDAQ:ZYNE) has a Return on Assets (ROA) of -48.1. The company currently has a Return on Equity (ROE) of -54.3 and a Return on Investment (ROI) of 0.